Richard Miller

发表

Roles and Interplay of SARS-CoV-2 Serology With Clinical Stages of Disease in COVID-19

K. H. Chan, J. Slim, M. Mutyala, 2021, Cureus.

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.

J. Barrett, M. Tremelling, M. Parkes, 2019, Gastroenterology.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Casey S. Greene, Marco Carbone, Andrew Fraser, 2015, Nature Communications.

X chromosome contribution to the genetic architecture of primary biliary cholangitis.

Aaron M. King, Elizabeth G. Atkinson, K. Siminovitch, 2021, Gastroenterology.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, Johshua N. Fletcher, 2019, The Lancet. Neurology.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, M. Dennis, 2019, Lancet.

Effects of fluoxetine on functional outcomes after acute stroke ( FOCUS ) : a pragmatic , double blind , randomised , controlled

Joshua R. Smith, Ashutosh Kumar Singh, Stephen H. Levy, 2019 .

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.